Your browser doesn't support javascript.
loading
Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue Sarcoma.
Bonvalot, Sylvie; Rutkowski, Piotr L; Thariat, Juliette; Carrère, Sébastien; Ducassou, Anne; Sunyach, Marie-Pierre; Agoston, Peter; Hong, Angela M; Mervoyer, Augustin; Rastrelli, Marco; Moreno, Victor; Li, Rubi K; Tiangco, Béatrice J; Herráez, Antonio Casado; Gronchi, Alessandro; Sy-Ortin, Teresa; Hohenberger, Peter; de Baère, Thierry; Cesne, Axel Le; Helfre, Sylvie; Saada-Bouzid, Esma; Anghel, Rodica M; Kantor, Guy; Montero, Angel; Loong, Herbert H; Vergés, Ramona; Kacso, Gabriel; Austen, Lyn; Servois, Vincent F; Wardelmann, Eva; Dimitriu, Mikaela; Said, Patricia; Lazar, Alexander J; Bovée, Judith V M G; Péchoux, Cécile Le; Pápai, Zsusanna.
Afiliação
  • Bonvalot S; Department of Surgical Oncology, Institut Curie, Paris University, Paris, France. Electronic address: sylvie.bonvalot@curie.fr.
  • Rutkowski PL; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Thariat J; Department of Radiation Oncology, Centre François Baclesse, Caen, France; Department of Radiation Oncology, Centre Lacassagne, Nice, France.
  • Carrère S; Department of Surgical Oncology, Centre Regional De Lutte Contre Le Cancer Paul Lamarque, Montpellier, France.
  • Ducassou A; Department of Radiation Oncology, Institut Claudius Regaud (ICR), Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-O), Toulouse, France.
  • Sunyach MP; Department of Radiotherapy, Léon Bérard Cancer Center, Lyon, France.
  • Agoston P; Centre Radiation Oncology, Országos Onkologiai Intézet, Budapest, Hungary.
  • Hong AM; Department of Radiation Oncology, Chris O'Brien Lifehouse and the University of Sydney, Camperdown, New South Wales, Australia.
  • Mervoyer A; Department of Radiation Oncology, Institut de Cancerologie de l'Ouest- Rene Gauducheau, Saint-Herblain, France.
  • Rastrelli M; Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padua, Padua, Italy; Department of Surgical Oncology, Veneto Institute of Oncology (IOV)-IRCCS, Padua, Italy.
  • Moreno V; Department of Medical Oncology, START Madrid-FJD, Hospital Fundación Jimenez Diaz, Madrid, Spain.
  • Li RK; Department of Medical Oncology, St. Luke's Medical Center, Quezon City, Philippines.
  • Tiangco BJ; Department of Medical Oncology, Medical City Cancer Center, Pasay City, Philippines.
  • Herráez AC; Department of Medical Oncology, Hospital Clínico Universitario San Carlos, Madrid, Spain.
  • Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Sy-Ortin T; Department of Radiation Oncology, Benavides Cancer Institute, University of Santo Tomas Hospital, Manila, Philippines.
  • Hohenberger P; Division of Surgical Oncology and Thoracic Surgery, Mannheim University Medical Center, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • de Baère T; Departement d'Anesthésie, de Chirurgie, et de Radiologie Interventionnelle, Université Paris-Saclay, Gustave Roussy, and Centre d'Investigation Clinique BIOTHERIS, INSERM CIC1428, Villejuif, France.
  • Cesne AL; Department of Medical Oncology, Gustave Roussy-Cancer Campus, Villejuif, France.
  • Helfre S; Department of Radiation Therapy, Institut Curie, PSL Research University, Paris, France.
  • Saada-Bouzid E; Department of Medical Oncology, Centre Anticancer Antoine Lacassagne, Nice, France.
  • Anghel RM; Institutul Oncologic Bucuresti Prof Dr Alexandru Trestioreanu and Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Kantor G; Department of Radiotherapy, Institut Bergonié, Comprehensive Cancer Center, and University of Bordeaux, Bordeaux, France.
  • Montero A; Radiation Oncology Department, Hospital HM Universitario Sanchinarro, Madrid, Spain.
  • Loong HH; Department of Clinical Oncology, Prince of Wales Hospital, Sha Tin, Hong Kong, China.
  • Vergés R; Radiation Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Kacso G; Iuliu Hatieganu University of Medicine and Pharmacy Cluj-Napoca, RTC Amethyst, Cluj, Romania.
  • Austen L; Department of Radiation Oncology, Canberra Region Cancer Centre, Garran, Australia.
  • Servois VF; Department of Radiology, Institut Curie, PSL Research University, Paris, France.
  • Wardelmann E; Gerhard Domagk Institute of Pathology, University Hospital Münster, Münster, Germany.
  • Dimitriu M; Nanobiotix SA, Paris, France.
  • Said P; Nanobiotix SA, Paris, France.
  • Lazar AJ; Departments of Pathology and Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bovée JVMG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Péchoux CL; Department of Radiation Oncology, Gustave Roussy-Cancer Campus, Villejuif, France.
  • Pápai Z; Medical Centre, Hungarian Defence Forces, Budapest, Hungary.
Int J Radiat Oncol Biol Phys ; 114(3): 422-432, 2022 11 01.
Article em En | MEDLINE | ID: mdl-35850363
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article